See the concurrent NY batch 
Stopping cancer at stage zero
Clear path to clinical trials within 3 years
Stopping cancer at stage zero
Revolutionizing beverage
10x better conservation of bioactive proteins
IndieBio has not seen a foodtech company take off this fast since we funded NotCo in 2017.
FloUV makes UV-C sterilization systems that are 4x cheaper and draw 10x less electricity than existing systems. These are used throughout the liquids and beverages sector – both in supply chains and in processing/packaging – across dairy, juices, coffee, syrups, water and water treatment, and even packaged pharmaceuticals and supplements.
You might take food safety for granted, but the world’s processors do not. FloUV’s system uses precision dosing and advanced fluid dynamics for highly targeted performance customized for every customer. We funded this company in July, and by the end of September, we had already shipped and tested pilot units that process 800 liters per hour. This has resulted in orders for units 20x to 30x larger, and we are currently negotiating over $5M in sales – all of which we intend to realize in 2026.
This company is riding the trend for gentler processing that doesn’t degrade bioactive proteins, potent flavor compounds, and critical nutrients. Yes, you can taste the difference! As consumers demand the quality of fresh food, but at the affordability and scale of processed food, FloUV is rapidly finding applications everywhere.
Check out our recent interview with the co-founders:
Better, cheaper animal feed
Extremely low capex: $100K yields $1.3M revenue.
In the $600 Billion commodity animal feed market, farmers are being squeezed from all angles. As feed prices continue to rise, they are desperate for solutions to lower their input costs while still maintaining animal health and performance. Gilly takes large volume agricultural byproducts which are already being used in feed at low inclusion rates, and processes them to have higher protein and better digestibility with minimal added opex. In just a 3 day cycle they can boost protein content in the feedstock by at least 40% Essentially, Gilly can turn varied agricultural byproducts into feed with the same nutritional quality as a bulk feed like soybean meal.
In our lab, Gilly has proven they can upcycle soybean hulls, tomato pomace, distillers grain, corn silage, almond hulls, and more. Gilly will deploy their technology in a distributed manner on large farms and colocate with feedstock suppliers, optimizing for minimal transportation costs.
A massive industry also necessitates massive scale. Gilly’s first market is feeding the 1.7M dairy cows in California. Already at ton scale, Gilly is initiating a feed trial in 130 cows with a Modesto dairy, where they will evaluate the impacts of their feed on palatability and milk production. They’ll be treating a fraction of the 3 tons of dry feed these animals eat per day. Success with just this one customer will unlock a 7 figure revenue opportunity. Cofounders Bo and Vince have deep expertise in both operating commercial scale farming operations and scaling biomanufacturing processes for large volume markets.
Check out our recent interview with the co-founders:
Sustainable Weight and Metabolic Health - For Everyone, Everywhere
Over 50% of people discontinue GLP-1 drug therapy within a year and all of them are desperately seeking alternative solutions for weight maintenance.
GLP-1s are rapidly on track to reach $100B of sales in the US by 2030, becoming a cornerstone of treatment for obesity and metabolic dysfunction. Yet, what most don’t know is that over half of GLP users cycle off the drug within one year! This might be due to cost, intolerable side effects, or simply that it doesn’t work for a particular person. As a result there is immense need for new tools to manage side effects, while helping patients maintain weight loss after coming off their GLP-1 drug.
Enter Metabolize. Based on discoveries from the lab of Dr. Jonathan Long, Stanford professor with decades of research into molecular mechanisms of energy homeostasis, Metabolize is bringing two supplements to market this summer for patients rolling off GLP-1s. Both products will be both sold as pills to consumers and can be included as an ingredient in nutritional foods. First, they have a molecule to prevent the loss of muscle mass that happens to over 60% of GLP users. Second, their hero product has been shown to induce significant weight loss in proof of concept animal models via a completely different mechanism than GLPs, with no observed safety and tolerability issues. Led by a very experienced physician entrepreneur, we think this might well be the consumer product that breaks through the noise of GLP-1 alternatives with a novel, science-backed mechanism plus the sweet safety of a supplement.
Check out our recent interview with the founder:
CPTI transforms surfaces into power sources with world-best perovskite films.
Their trusted original equipment manufacturer (OEM) allows them to grow fast and already be a commercial-stage company with industrial customers, less than a year after inception
As the physical world becomes smarter with AI onboard, it means every electronic device, every sensor, and every robot will run algorithms at the edge. In turn, this means greater demand at the edge for juice, for power.
CPTI meets this demand by turning every surface, of any shape or flexibility needed, into a light-harvesting, self-charging power source. Already a commercial stage company with several industrial customers, CPTI quickly has reached the world’s best power density and world best surface thinness, enabled by the inclusion of world record performance perovskites. This enables a very inexpensive nanomaterial manufacturing process that resembles inkjet printing, facilitating a 90% margin. And they’ve set up a manufacturing supply chain which is ready to scale fast.
Starting in devices and electronics, then moving to mobility, buildings, utility markets with scale. Imagine biometric watches that never need charging. TV remotes that never need the battery replaced. Field work tablets that work more hours. Cameras and sensors that don’t need an electricity source.
Check out our recent interview with the cofounders:
